These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 22999746)

  • 21. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of chemoembolization for recurrent HCC after curative ablation therapy.
    Okabe N; Morimoto M; Kondo M; Moriya S; Numata K; Maeda S; Tanaka K
    Hepatogastroenterology; 2013 May; 60(123):395-99. PubMed ID: 23108088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
    Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
    PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments.
    Santambrogio R; Costa M; Strada D; Bertolini E; Zuin M; Barabino M; Opocher E
    Ultrasound Med Biol; 2011 Jan; 37(1):7-15. PubMed ID: 21084155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.
    Toshikuni N; Takuma Y; Goto T; Yamamoto H
    Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
    Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated percutaneous radiofrequency ablation for hepatocellular carcinoma in patients with cirrhosis: assessment of safety based on liver function and portal hypertension parameters.
    Lee S; Jeong WK; Rhim H
    J Vasc Interv Radiol; 2014 Oct; 25(10):1573-9. PubMed ID: 25108816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
    Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.